# Zhigui Zheng

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zhigui-zheng/

## Facts

| Field | Value |
| --- | --- |
| Citations | 75 |
| Field | Dialysis and Renal Disease Management |
| h-index | 5 |
| i10-index | 3 |
| Last Known Institution | Zhejiang Hospital |
| OpenAlex ID | https://openalex.org/A5075851313 |
| ORCID iD | 0000-0001-5994-8320 |
| Works | 11 |

## Researcher papers

- [Continuous Versus Intermittent use of Furosemide in Patients with Heart Failure and Moderate Chronic Renal Dysfunction](https://scholariq.org/papers/continuous-versus-intermittent-use-of-furosemide-in-patients-with-heart-failure/)
- [Risk of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials](https://scholariq.org/papers/risk-of-urinary-tract-infection-in-patients-with-type-2-diabetes-mellitus/)
- [The Effect of Allopurinol on Renal Outcomes in Patients with Diabetic Kidney Disease: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/the-effect-of-allopurinol-on-renal-outcomes-in-patients-with-diabetic-kidney/)
- [The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients](https://scholariq.org/papers/the-effects-of-megestrol-acetate-on-nutrition-inflammation-and-quality-of-life/)
- [Manganese( <scp>iii</scp> ) acetylacetonate initiated RAFT polymerizations: an alternative and versatile RAFT initiator](https://scholariq.org/papers/manganese-scp-iii-scp-acetylacetonate-initiated-raft-polymerizations-an/)
- [Role and Mechanism of Epithelial-Mesenchymal Transition Mediated by Inflammatory Stress-Induced TGF-β1 in Promoting Arteriovenous Fistula Stenosis](https://scholariq.org/papers/role-and-mechanism-of-epithelial-mesenchymal-transition-mediated-by-inflammatory/)
- [The efficacy and safety of low-dose roxadustat in combination with recombinant human erythropoietin for treating hemodialysis patients with moderate anemia: A retrospective cohort study](https://scholariq.org/papers/the-efficacy-and-safety-of-low-dose-roxadustat-in-combination-with-recombinant/)
- [Risk of urinary tract infection in patients with type 2 diabetes treated with dapagliflozin: A systematic review and meta-analysis of randomized controlled studies](https://scholariq.org/papers/risk-of-urinary-tract-infection-in-patients-with-type-2-diabetes-treated-with/)
- [Lower Urinary Tract Symptoms in Males](https://scholariq.org/papers/lower-urinary-tract-symptoms-in-males/)
- [Exostosin 1/exostosin 2-associated membranous nephropathy in undifferentiated connective tissue disease: a case report and literature review](https://scholariq.org/papers/exostosin-1-exostosin-2-associated-membranous-nephropathy-in-undifferentiated/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Urinary Tract Infections Management](https://scholariq.org/topics/urinary-tract-infections-management/)
- [Organometallic Complex Synthesis and Catalysis](https://scholariq.org/topics/organometallic-complex-synthesis-and-catalysis/)

## Researcher university

- [Zhejiang Hospital](https://scholariq.org/institutions/zhejiang-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.